Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 19Neoplasms 12Colorectal Neoplasms 5Pain, Postoperative 4Fatigue 4Thyroid Neoplasms 3Stomatitis 3Pain 3Malnutrition 3Liver Neoplasms 3Depression 3Carcinoma, Hepatocellular 3Anxiety Disorders 3Stomach Neoplasms 2Sleep Initiation and Maintenance Disorders 2Polycystic Ovary Syndrome 2Parasomnias 2Motor Activity 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Breast Cancer Female 2Agnosia 2Weight Loss 1Vomiting 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Incontinence 1Unilateral U/S PVB 1Ulcer 1

Interventions

Surveys and Questionnaires 5Pemetrexed 3Paclitaxel 3Gemcitabine 3Docetaxel 3Brachytherapy 3pembrolizumab 2Topotecan 2Saline Solution 2Radiotherapy 2Radiation 2FANG vaccine 2Everolimus 2Doxorubicin 2Cisplatin 2Carboplatin 2CP protocol 2temsirolimus 1selinexor 1osimertinib 1niraparib 1fosaprepitant 1ferumoxtran-10 1ferrous fumarate 1durvalumab 1cobimetinib 1atezolizumab 1alovudine 1Vitamin D 1Uterine Artery Embolization 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Uterine Neoplasms × Control Groups × Clear all
NCT02896413 2021-05-04

The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection

Yonsei University

Phase NA Completed
100 enrolled
Gynecologic

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡